T1	Participants 16 22	stroke
T2	Participants 79 95	elderly patients
T3	Participants 1242 1277	older individuals with hypertension
T4	Participants 325 355	hypertension in older patients
T5	Participants 357 749	Since 1991, the results of 3 major trials--the British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating older patients (> 60 years) with both diastolic and isolated systolic hypertension
